News

The new unit has been supported by a £145,000 grant from Scottish Enterprise, reports inpharm.com. The Scottish deputy minister Nicola Sturgeon has inaugurated the ADC facility, which integrates

FDA reported that the facility is failing to perform adequate product testing and is practicing inadequate labelling or documentation of its drug products, The Globe And Mail reported.

The patent covers the synergistic effects of combination therapies containing COTI-2 and members of other classes of anti cancer agents. This patent provides extra protection for COTI-2 in

As per the agreement, Minophagen will have the exclusive rights to develop and commercialize the drug candidate. Eisai holds the right of first negotiation for the commercialization of

The recall was issued because cracks can form in the heel (bottom) and sides of some vials of 1662, 1679, and 1683 lots. The cracks may lead to

The payment was triggered by the approval of an investigational new drug (IND) application from the FDA for the Phase I trial for a Nanobody. Both the companies

Airborne develops and sells immune support products including iconic effervescent tablets, new chewable tablets and on-the-go packets, all in a variety of flavors. The all-cash transaction is done

MusclePharm CEO Brad Pyatt said Canada is a core market for Fitness as well as the Mecca for Ultimate Fighting Championship (UFC). "In the next 36 months, we

Kiklin capsules, amine-functional polymers, bind to phosphate in the gastrointestinal tract and decrease the serum phosphorus concentration, there by inhibiting absorption of phosphate into the human body. Phase